HEALTH-RELATED QUALITY OF LIFE IN POORLY CONTROLLED TYPE 2 DIABETES PATIENTS - ASSOCIATION OF PATIENTS' CHARACTERISTICS WITH EQ-5D DOMAINS, MEAN EQ-5D SCORES, AND VISAUL ANALOG SCALE SCORE
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i1.19120Keywords:
Health-related quality of life, EQ-5D, Diabetes mellitus, Randomized controlled studyAbstract
Â
 Objective: High prevalence of diabetes mellitus in Malaysia demands the appropriate interventions to alleviate or postpone its burden on patients' health-related quality of life (HRQoL). The studies which provide useful knowledge about the components of such interventions are important. The aim of this study was to describe how demographic and clinical characteristics of diabetes patients influence their HRQoL using EQ-5D.
Methods: This study used the baseline data of a randomized controlled study carried out to examine the impact of a pharmacist intervention on poorly controlled diabetes patients. A generic HRQoL tool EQ-5D was used to report the data. Logistic regression was used to identify the predictors of problems in individual EQ-5D domains, and ANCOVA was undertaken to examine the effect of patients' characteristic on EQ-5D mean scores and visual analog scale (VAS) mean scores.
Results: Pain discomfort was reported to be significantly predicted by high HbA1c levels. Increasing age (OR =1.04; CI 1.01, 1.16) and increasing body mass index (OR = 1.15; CI 1.01, 1.30) were significant predictors of reduced mobility. The presence of complications (OR = 8.03; CI 1.34–48.02) and (5–10 years) diabetes duration predicted the reduced score in anxiety domain (OR = 7.05; CI 1.03, 48.04). Problems in usual activities were significantly predicted by age (OR = 1.4; CI 1.01, 1.18). Self-care was not affected by any of the model covariates. Mean EQ-5D score was (0.89; CI 0.85, 0.92) significantly predicted by HbA1c values (p=0.04). Mean VAS score (70.54) was significantly lower in the group receiving insulin (69.46; CI 73.74, 84.02) than the oral diabetes medication (78.88; CI 64.94, 73.98) (p=0.009).
Conclusion: Patients' characteristics were significantly associated with the HRQoL in type 2 diabetes. There was a significant and inverse association of HRQoL with medication group (insulin use), high HbA1c, obesity, and presence of complications.
Downloads
References
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
Fallowfield L. What is Quality of Life? 2009. Available from: http://www.medicine.ox.ac.uk/bandolier/painres/download/whatis/ WhatisQOL.pdf.
Wan Nazaimoon WM, Md Isa SH, Wan Mohamad WB, Khir AS, Kamaruddin NA, Kamarul IM, et al. Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion. Diabet Med 2013;30:825-8.
Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, Chandran LR, Tee GH, Jamaiyah H, et al. Prevalence of diabetes in the Malaysian national health morbidity survey III 2006. Med J Malaysia 2010;65:180-6.
Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: A systematic review of studies in Iran. J Diabetes Metab Disord 2013;12:54.
Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metabol Res Rev 1999;15:205-18. 7. Sikdar KC, Wang PP, MacDonald D, Gadag VG. Diabetes and its impact on health-related quality of life: A life table analysis. Qual Life Res 2010;19:781-7.
Wee HL, Cheung YB, Li SC, Fong KY, Thumboo J. The impact of diabetes mellitus and other chronic medical conditions on health-related quality of life: Is the whole greater than the sum of its parts? Health Qual Life Outcomes 2005;3:2.
Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010;8:18.
Brown GC, Brown MM, Sharma S, Brown H, Gozum M, Denton P. Quality of life associated with diabetes mellitus in an adult population. J Diabetes Complications 2000;14:18-24.
Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm 2006;63:2116-22.
Butt M, Mhd Ali A, Bakry MM, Mustafa N. Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled study. Saudi Pharm J 2016;24:40-8.
Johnson CL, Nicholas A, Divine H, Perrier DG, Blumenschein K, Steinke DT. Outcomes from DiabetesCARE: A pharmacist-provided diabetes management service. J Am Pharm Assoc 2008;48:722-30.
Kamarul Imran M, Ismail AA, Naing L, Wan Mohamad WB. Type 2 diabetes mellitus patients with poor glycaemic control have lower quality of life scores as measured by the Short Form-36. Singapore Med J 2010;51:157-62.
Mafauzy M. Diabetes control and complications in public hospitals in Malaysia. Med J Malaysia 2006;61:477-83.
Lim PC, Lim K. Evaluation of a pharmacist-managed diabetes medication therapy adherence clinic. Pharm Pract (Granada)2010;8:250-4.
Chew BH, Mohd-Sidik S, Shariff-Ghazali S. Negative effects of diabetes-related distress on health-related quality of life: An evaluation among the adult patients with Type 2 diabetes mellitus in three primary healthcare clinics in Malaysia. Health Qual Life Outcomes 2015;13:187.
Daher AM, AlMashoor SA, Winn T. Glycaemic control and quality of life among ethnically diverse Malaysian diabetic patients. Qual Life Res 2015;24:951-8.
Goh SG, Rusli BN, Khalid BA. Diabetes quality of life perception in a multiethnic population. Qual Life Res 2015;24:1677-86.
Cheah W, Lee P, Lim P, Fatin Nabila A, Luk K, Nur Iwana A. Perception of quality of life among people with diabetes. Malays Fam Physician 2012;7:21-30.
Sakamaki H, Ikeda S, Ikegami N, Uchigata Y, Iwamoto Y, Origasa H, et al. Measurement of HRQL using EQ-5D in patients with Type 2 diabetes mellitus in Japan. Value Health 2006;9:47-53.
Mehta Z, Cull C, Stratton I, Yudkin J. Quality of life in Type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22:1125-36.
Yusof FA, Goh A, Azmi S. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Value Health 2012;15 1 Suppl: S85-90.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63.
Shim YT, Lee J, Toh MP, Tang WE, Ko Y. Health-related quality of life and glycaemic control in patients with Type 2 diabetes mellitus in Singapore. Diabet Med 2012;29:e241-8.
Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in Type 2 diabetes. Diabetes Care 2006;29:1518-22.
Bruce DG, Davis WA, Davis TM. Longitudinal predictors of reduced mobility and physical disability in patients with Type 2 diabetes: The fremantle diabetes study. Diabetes Care 2005;28:2441-7.
Orr R, Raymond J, Singh MF. Efficacy of progressive resistance training on balance performance in older adults. Sports Med 2008;38:317-43.
Lau CY, Qureshi AK, Scott SG. Association between glycaemic control and quality of life in diabetes mellitus. J Postgrad Med 2004;50:189-93.
Almeida OP, McCaul K, Hankey GJ, Yeap BB, Golledge J, Norman PE, et al. Duration of diabetes and its association with depression in later life: The health in men study (HIMS). Maturitas 2016;86:3-9.
Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med 2008;121 11 Suppl 2:S8-15.
Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence and determinants of depression in Type 2 diabetes patients in a tertiary care centre. Indian J Med Res 2010;132:195-200.
Thour A, Das S, Sehrawat T, Gupta Y. Depression among patients with diabetes mellitus in North India evaluated using patient health questionnaire-9. Indian J Endocrinol Metab 2015;19:252-5.
Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with Type 2 diabetes not using insulin. Value Health 2001;4:392-400.
Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes. Diabetes Care 2002;25:458-63.
Al-Aboudi IS, Hassali MA, Shafie AA, Hassan A, Alrasheedy AA. A cross-sectional assessment of health-related quality of life among Type 2 diabetes patients in Riyadh, Saudi Arabia. SAGE Open Med 2015;3:2050312115610129.
Javanbakht M, Abolhasani F, Mashayekhi A, Baradaran HR, Jahangiri Noudeh Y. Health related quality of life in patients with Type 2 diabetes mellitus in Iran: A national survey. PLoS One 2012;7:e44526.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.